Luke O'Neill

28PUBLICATIONS
131CO-AUTHORS
Gene and molecular therapyInnate immunityChemical engineering designMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Sep 23, 2025
Adenosine 2A receptor-dependent activation of AMPK represses TH17 cell pathogenicity through epigenetic and metabolic reprogramming.

Gina Papadopoulou, Dimitrios Valakos, Ioanna Polydouri

|Mar 07, 2025
Trained immunity causes myeloid cell hypercoagulability.

Aisling M Rehill, Seán McCluskey, Anna E Ledwith

|Jan 22, 2025
Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasion.

Alessia Zotta, Juliana Toller-Kawahisa, Eva M Palsson-McDermott

|Oct 31, 2024
Rhythmic IL-17 production by γδ T cells maintains adipose de novo lipogenesis.

Aaron Douglas, Brenneth Stevens, Miguel Rendas

|Oct 15, 2024
Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenase.

Shane M O'Carroll, Christian G Peace, Juliana E Toller-Kawahisa

|Jul 26, 2024
Metabolic Messengers: itaconate.

A F McGettrick, L A Bourner, F C Dorsey

Pageof 5

Frequent Collaborators

8 joint publications

Emily Anne Day

6 joint publications

Anne F McGettrick

6 joint publications

Alexander Hooftman

5 joint publications

Tristram Alexander Jasper Ryan